Does 0600T require prior authorization?

No, 0600T does not require prior authorization (high confidence). Code is covered without prior authorization.

What is the Medicare reimbursement rate for 0600T?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

HCPCS/CPT

No Prior Auth Required

Code is covered without prior authorization (high confidence)

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

This article provides billing, coding, and guideline information that complements the Local Coverage Determination DL40205 for Irreversible Electroporation for Cancer; refer to LCD DL40205 for clinical coverage criteria.
Minimum 5-year follow-up period documented after focal therapy.
Multiparametric MRI results during follow-up.
Follow-up biopsy reports.

Whole-gland cryosurgical ablation as initial treatment for clinically localized (organ-confined) prostate cancer.
Whole-gland cryosurgical ablation as salvage treatment for prostate cancer recurring after radiation therapy.
Whole-gland cryoablation as a percutaneous procedure to treat localized prostate cancer by freezing and thawing prostate tissue to induce tumor necrosis.
Whole-gland (total) cryoablation for treatment of clinically localized prostate cancer as an alternative to radical prostatectomy or external-beam radiotherapy.
Whole-gland cryoablation as salvage therapy for nonmetastatic relapse after initial treatment of clinically localized prostate cancer.
Subtotal (focal) prostate cryoablation for treatment of localized prostate cancer (focal treatment of the gland).

A60221 — Billing and Coding: Irreversible Electroporation for Cancer

L40204 — Irreversible Electroporation for Cancer

BCBSIL-SUR717.004 — Focal Treatments for Prostate Cancer

BCBSMT-SUR717.004 — Focal Treatments for Prostate Cancer

BCBSNM-SUR717.004 — Focal Treatments for Prostate Cancer

Ask Verity about documentation requirements, denial risks, or coverage in your state.